Lysosomotropic challenge of mast cells causes intra-granular reactive oxygen species production

Aida Paivandy1, Jens Eriksson2, Fabio Rabelo Melo1

  • 11Uppsala University, Department of Medical Biochemistry and Microbiology, Uppsala, Sweden.

Insights

Lysosomotropic agents induce apoptosis in mast cells by causing reactive oxygen species (ROS) production within secretory granules. Granule acidification is crucial for this ROS generation and subsequent mast cell death.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Mast cells play a role in allergic and other diseases.
  • Targeting mast cell activity is a therapeutic strategy.
  • Previous work established inducing mast cell apoptosis via lysosomotropic agents.

Purpose of the Study:

  • Investigate the mechanism of reactive oxygen species (ROS) production in mast cells.
  • Identify the subcellular location of ROS production.
  • Elucidate the role of granule acidification in mast cell apoptosis.

Main Methods:

  • Live microscopy analysis of mast cells treated with mefloquine.
  • Assessment of ROS production and cell death.
  • Utilizing mast cells lacking serglycin.
  • Inhibiting granule acidification, using an iron chelator, and inhibiting granzyme B or ERK1/2 MAP kinase.

Main Results:

  • Secretory granules are major sites of ROS production in mast cells.
  • ROS production and cell death were reduced in mast cells lacking serglycin.
  • Inhibition of granule acidification blocked ROS production and cell death.
  • Iron chelation and inhibition of granzyme B or ERK1/2 attenuated ROS production.

Conclusions:

  • Mast cell secretory granules are key sites for ROS production under lysosomotropic challenge.
  • Granule acidification is essential for ROS generation and mast cell apoptosis.
  • This mechanism offers a potential target for treating mast cell-mediated disorders.

Related Concept Videos

What is a Species?01:17

What is a Species?

Overview
49.5K
Formation of Species01:31

Formation of Species

Speciation describes the formation of one or more new species from one or sometimes multiple original species. The resulting species are discrete from the parent species, and barriers to reproduction will typically exist. There are two primary mechanisms, speciation with and without geographic isolation—allopatric and sympatric speciation, respectively.
44.8K
Keystone Species01:39

Keystone Species

Measures of species biodiversity, such as richness (i.e., the number of species present) and evenness (i.e., their relative abundance), describe an ecological community’s structure. Many factors affect community structure, including abiotic factors (e.g., sunlight and nutrients), disturbances (e.g., fire or flood), species interactions (e.g., predation or competition), and chance events (e.g., foreign species invasion). Certain species—such as keystone species—also play a...
24.2K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Cross-reactivity00:42

Cross-reactivity

Overview
32.9K
Reactivity of Enols01:18

Reactivity of Enols

Enols are a class of compounds where a hydroxyl group is attached to a carbon–carbon double bond, which implies that it is a vinyl alcohol. A carbonyl compound with an α hydrogen undergoes keto–enol tautomerism and remains in equilibrium with its tautomer, the enol form. Usually, the keto tautomer is present in a higher concentration than the enol tautomer due to the higher bond energy of C=O compared to C=C. Moreover, the direction of the keto–enol equilibrium is...
4.0K